Schubert & CO Bristol Myers Squibb CO Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $6,373 - $7,229	-97 Reduced 26.65%	267 $18,000
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $7,601 - $9,000	111 Added 43.87%	364 $26,000
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $10 - $6,147	-80 Reduced 24.02%	253 $18,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $13,144 - $14,476	181 Added 119.08%	333 $26,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $3,258 - $3,907	53 Added 53.54%	152 $11,000
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $5,309 - $6,189	99 New	99 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.